小胶质细胞
先天免疫系统
神经科学
背景(考古学)
胶质增生
神经炎症
免疫
生物
疾病
神经退行性变
免疫系统
神经毒性
认知功能衰退
获得性免疫系统
免疫学
先天性淋巴细胞
医学
模式识别受体
阿尔茨海默病
炎症
病理
痴呆
古生物学
内科学
毒性
作者
Marie-Victoire Guillot-Sestier,Terrence Town
出处
期刊:Cns & Neurological Disorders-drug Targets
[Bentham Science Publishers]
日期:2013-07-31
卷期号:12 (5): 593-607
被引量:65
标识
DOI:10.2174/1871527311312050008
摘要
Alzheimer's disease (AD) is characterized by three major histopathological hallmarks: β-amyloid deposits, neurofibrillary tangles and gliosis. While neglected for decades, the neuroinflammatory processes coordinated by microglia are now accepted as etiologic events in AD evolution. Microglial cells are found in close vicinity to amyloid plaques and display various activation phenotypes determined by the expression of a wide range of cytokines, chemokines, and innate immune surface receptors. During the development of AD pathology, microglia fail to restrict amyloid plaques and may contribute to neurotoxicity and cognitive deficit. Nevertheless, under specific activation states, microglia can participate in cerebral amyloid clearance. This review focuses on the complex relationship between microglia and Aβ pathology, and highlights both deleterious and beneficial roles of microglial activation states in the context of AD. A deeper understanding of microglial biology will hopefully pave the way for next-generation AD therapeutic approaches aimed at harnessing these enigmatic innate immune cells of the central nervous system.
科研通智能强力驱动
Strongly Powered by AbleSci AI